Heart rhythm ablation outcomes in minority patients
Part of Heart & circulation clinical trials.
This registry tracks outcomes for racial and ethnic minority patients undergoing a specific type of heart rhythm treatment (ablation) for atrial fibrillation. The goal is to understand how well this treatment works across different populations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as a racial or ethnic minority
- You have atrial fibrillation (AFib) that your doctor recommends treating with ablation
- Your AFib has lasted less than 1 year, or is paroxysmal (comes and goes)
- This would be your first ablation procedure, or your first one was also in this registry
- You are age 18 or older
- You can attend baseline and follow-up appointments throughout the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This study looks at how a new type of heart procedure, called pulsed field ablation, affects the heart's structure in people with persistent atrial fibrillation. It may help doctors understand if this treatment improves heart function over time.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial compares two ways to treat persistent atrial fibrillation (an irregular heartbeat that lasts for months or years). One method uses pulsed field energy and the other uses radiofrequency heat to fix the heart's electrical signals. The goal is to see which method is safer and more effective for patients having their first ablation procedure.
This trial tests a newer treatment called pulsed field ablation (PFA) for people with paroxysmal atrial fibrillation (AF), where the heart's rhythm is irregular and comes and goes on its own within 7 days. The goal is to see if PFA can restore a normal heart rhythm while better protecting the heart's left atrial function, which helps pump blood effectively. If you have AF and medications haven't worked, this could be an option to discuss with your doctor.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.